← Every company
Roivant Sciences Ltd SEC Filings
What Roivant Sciences Ltd has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
ROIV overview →Filings on file
74
since May 14, 2021
Warning signs
0
none filed
Last results
Aug 6, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Mar 20, 2025 | Executive or director change 8-K | Read ↗ |
| Feb 21, 2025 | Executive or director change 8-K | Read ↗ |
| Aug 4, 2023 | Executive or director change 8-K | Read ↗ |
| Mar 16, 2023 | Executive or director change 8-K | Read ↗ |
| Feb 21, 2023 | Executive or director change 8-K | Read ↗ |
| Nov 23, 2022 | Executive or director change 8-K | Read ↗ |
| Sep 21, 2022 | Executive or director changeMaterial agreementShareholder vote 8-K | Read ↗ |
| Jun 28, 2022 | Executive or director changeResults announced 8-K | Read ↗ |
| Oct 1, 2021 | Executive or director changeMaterial agreementUnregistered share sale 8-K | Read ↗ |
Source: Roivant Sciences Ltd's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.